Mockel, Martin, Muller, Reinhold, Vollert, Jörn O., Muller, Christian, Carl, Angelika, Peetz, Dirk, Post, Felix, Koshe, J. Klaus, and Lackner, Karl J. (2005) Role of N-terminal pro-B-type natriuretic peptide in risk stratification in patients presenting in the emergency room. Clinical Chemistry , 51 (9). pp. 1624-1631.

PDF (Published Version) Restricted to Repository staff only

 

23

4

Abstract

Background: Natriuretic peptides are promising markers in diagnosing acute and chronic heart failure and assessing prognosis in these patients. Increasing routine use to unselected patients is challenged by false-positive results. The aims of this study were to assess (a) the distributions of N-terminal B-type natriuretic peptide (NT-proBNP) values in various diagnostic groups, (b) factors that influence NT-proBNP, and (c) the value of NT-proBNP in risk stratification in unselected emergency room (ER) patients. Methods: NT-proBNP was measured in 876 unselected consecutive patients [mean (SD) age, 58 (18) years; 53% male] attending the ERs of 2 university hospitals and 1 community hospital. Diagnoses, age, sex, hemoglobin, creatinine (CREA), C-reactive protein (CRP), troponin T, and intensity of care were documented. In a subset consisting of all 417 patients at 1 center, in-hospital follow-up was completed with respect to a complicated clinical course, including intensive care treatment and death. Results: NT-proBNP was significantly increased in patients with cardiac diagnoses or histories compared with patients with only pulmonary or other diagnoses. In patients with other diagnoses, NT-proBNP values increased significantly with the number of atherosclerotic risk factors (P = 0.044). Age, renal function, CRP, and to a much lesser extent, hemoglobin significantly influenced NT-proBNP values. The amount of care was positively correlated with NT-proBNP (P <0.001). Classification and regression tree analysis showed a superior impact of NT-proBNP for identification of high-risk patients. Conclusions: NT-proBNP is a promising marker for identification of patients with structural heart disease in the ER and a suitable tool for risk stratification. Its use in the ER should be limited to clearly clinically defined patient groups at present to avoid a potential excess of additional diagnostic procedures in positive but asymptomatic patients.

Actions (Repository Staff Only)

Item Control Page